Cardiac Rhythm Management Devices Market in China 2016-2020

Cardiac rhythm management devices market growth in China

Technavio’s market research analyst predicts the cardiac rhythm management devices market in China to grow at an impressive CAGR of around 10% by 2020. Rising incidences of cardiac disorders such as atrioventricular blocks, ventricular fibrillation, cardiac arrest, bradycardia, sick sinus syndrome, and tachycardia are expected to increase the demand for cardiac rhythm management devices in China during the forecast period.

With aging, heart muscles lose their elasticity and ability to respond to different pressure rates which makes older people more susceptible to cardiac disorders. The rising incidences of cardiac disorders, especially in the aging populace, will bolster the market growth for cardiac rhythm management devices until the end of 2020.

Cardiac rhythm management devices market drivers

With the increasing popularity of robot-assisted cardiac surgery, the market for cardiac rhythm management devices is expected to have a positive outlook until the end of 2020. The robot-assisted devices help surgeons perform sophisticated procedures by providing a better visualization platform and maneuvering of instruments compared to traditional devices. Also, these minimally invasive surgical procedures help reduce the duration of hospital stays and facilitate better cost management. The preference for robotic-assisted surgery is expected to drive the market growth for cardiac rhythm management devices in China during the forecast period.

CRM device market size worth by product segmentation

• Pacemakers
• Implantable cardioverter defibrillator (ICDs)
• Cardiac resynchronization therapy (CRT) devices

In this market research, the analyst predicts the pacemakers segment will dominate the market with a market share of close to 64% until the end of 2020. Pacemakers use low-energy electric pulses to induce the patient’s heart to beat at a normal rate. The new-generation pacemakers can adjust heartbeat rate based on the patient’s activity.

Cardiac rhythm management devices market share: Competitive landscape and key vendors

The cardiac rhythm management devices market in China presents significant opportunities for the vendors to expand. Both large and small companies are investing substantially in R&D to develop innovative products. The demand for cost-effective cardiac rhythm management devices has also led the local manufacturers to develop new-age products.

The leading vendors in the cardiac rhythm management devices market

• BIOTRONIK
• Boston Scientific
• LivaNova
• Medtronic

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the cardiac rhythm management devices market in China?
• What are the key market trends impacting the growth of the cardiac rhythm management devices market in China?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the vendors in the cardiac rhythm management devices market in China?
• What are the trending factors influencing the market shares of China?
• What are the key outcomes of the five forces analysis of the cardiac rhythm management devices market in China?

Related Reports

• Global Cardiac Rhythm Management Devices Market 2015-2019
• Global Cardiac Prosthetic Devices Market 2015-2019 
• Global Cardiac Resynchronization Therapy (CRT) Devices Market 2015-2019
• Cardiac Resynchronization Therapy Devices Market in Europe 2015-2019